Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedRecruitment status updated to indicate enrollment is closed. The record history now shows a new revision tag 'Revision: v3.6.0' and the removal of the previous 'Revision: v3.5.5' tag.SummaryDifference0.3%

- Check9 days agoChange DetectedThe history now includes a new revision entry for v3.5.5, replacing the previous v3.5.4. This reflects a small update to the page's revision metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a backend/platform update behind the page. No study content or status information is affected.SummaryDifference0.1%

- Check45 days agoChange DetectedThe Record History now shows the latest version as Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedUpdated the study’s overall status to **Completed** and revised its **Recruitment Status**. The prior **Active, not recruiting** state was removed.SummaryDifference0.4%

- Check59 days agoChange DetectedRevision: v3.5.2 has been added, replacing Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.